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Background: The adverse health and equity impacts of transnational corporations’ (TNCs) practices have become
central public health concerns as TNCs increasingly dominate global trade and investment and shape national
economies. Despite this, methodologies have been lacking with which to study the health equity impacts of
individual corporations and thus to inform actions to mitigate or reverse negative and increase positive impacts.
Methods: This paper reports on a framework designed to conduct corporate health impact assessment (CHIA),
developed at a meeting held at the Rockefeller Foundation Bellagio Center in May 2015.
Results: On the basis of the deliberations at the meeting it was recommended that the CHIA should be based on ex
post assessment and follow the standard HIA steps of screening, scoping, identification, assessment, decision-making
and recommendations. A framework to conduct the CHIA was developed and designed to be applied to a TNC’s
practices internationally, and within countries to enable comparison of practices and health impacts in different
settings. The meeting participants proposed that impacts should be assessed according to the TNC’s global and
national operating context; its organisational structure, political and business practices (including the type, distribution
and marketing of its products); and workforce and working conditions, social factors, the environment, consumption
patterns, and economic conditions within countries.
Conclusion: We anticipate that the results of the CHIA will be used by civil society for capacity building and advocacy
purposes, by governments to inform regulatory decision-making, and by TNCs to lessen their negative health impacts
on health and fulfil commitments made to corporate social responsibility.
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A major challenge for public health in the twenty-first
century is to respond to the changing dynamics of capit-
alist economies and the attendant impacts on people’s
daily living conditions, and ultimately health equity.
Central to this process has been the growth in the power
and influence of transnational corporations (TNCs).
Since TNCs increasingly dominate global trade and
investment and shape national economies, the adverse
health and equity impacts of their practices are now* Correspondence: fran.baum@flinders.edu.au
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researchers have not yet developed the tools or methods
with which to study the health equity impacts (both
positive and negative) of individual corporations and
thus to inform actions to mitigate and reverse negative
health impacts and reinforce any positive impacts. This
paper reports on the process of developing a framework
designed to conduct corporate health impact assessment,
the insights generated by this process and the resultant
framework, developed at a meeting held at the
Rockefeller Foundation Bellagio Center in May 2015.
The paper also discusses ideas canvassed at the meeting
regarding the feasibility of conducting such impact as-
sessment and its likely benefits to public health. Thele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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impact of TNCs in the food and mining sectors, the
evaluation and assessment of health impacts, and civil
society activists who advocate reversing adverse impacts.
Public health significance of TNCs
Transnational corporations (TNCs) are incorporated or
unincorporated enterprises operating across multiple
countries comprising parent enterprises and their for-
eign affiliates. It is estimated that there are now over
100,000 TNCs operating globally [1]. Many TNCs are
economies which are larger than those of national states
(see Fig. 1) [2]. Of the 100 governments and corpora-
tions with the highest annual revenues in 2014, 63 are
corporations [3] and 37 are governments [4]. This
growth is facilitated by the broader global context which
promotes neoliberal policies, including trade liberalisa-
tion, producer subsidies and strengthened private prop-
erty rights. The growth is also driven by growing
demand for TNC products in developing countries. A
growing body of research has examined the practices of
TNCs in sectors such as food and beverage, tobacco,
pharmaceuticals and extractive industries. It shows that
TNC products and operations can support gains in pub-
lic health through investment in host countries which
contributes to improvements in employment opportun-
ity, working conditions, education, infrastructure or
health service provision [5]. Some TNCs also undertake
practices intended to assess and improve performance in
areas of environmental impact, social accountability or
‘shared value’ [6]. Freudenberg argues, however, thatFig. 1 Comparing the size of the world’s largest corporations with selectedover the past two decades world economic arrangements
have been increasingly changed to suit the needs of cor-
porations and “as a result set the stage for the twenty-
first century disease epidemics” [7]. The UN Special
Rapporteur on the Right to Food said that the global
food system which is largely run by TNCs “is a public
health disaster” [8]. The Commission on the Social De-
terminants of Health [9] noted that binding trade agree-
ments together with increasing corporate power and
capital mobility have diminished individual countries’
capacities to ensure that economic activity contributes
to health equity, or at least does not undermine it. The
Lancet—University of Oslo Commission on Global Gov-
ernance for Health noted that “Private firms have an in-
fluential role in contemporary global governance. Large
transnational companies wield tremendous economic
power, which they can deploy to further their interests
in global governance processes and global markets” [10].
The Commission went on to note that, although there
were benefits from the operation of TNCs, “they can
also harm health through dangerous working conditions,
inadequate pay, environmental pollution, or by produ-
cing goods that are a threat to health (e.g., tobacco)” [9].
In addition to these powerful voices the Director Gen-
eral of the World Health Organization [11] has pointed
to the power of TNCs and the ways in which they can
influence the public health agenda adversely. An increas-
ing amount of research indicates that while there are
some positive effects there are significant negative im-
pacts on health from corporate structures, products and
practices (see Table 1).countries.2
Table 1 Examples of TNC impacts on health
Transnational corporations operate in many sectors including food
and beverages, extractive industries, tobacco, alcohol and
pharmaceuticals. They have the capacity to both promote and
harm health. Examples of beneficial health impacts from TNCs
include a range of shared value initiatives:
• Mars (chocolate) engaging in sustainable cocoa initiatives through
employing science, technology, and certification to assist farmers
through increasing yields and sustainable supply [21].
• Nestlé adding micronutrients including iron and iodine to foods to
improve health in impoverished regions [22].
• BHP Billiton improving the quality and reliability of local suppliers
through the “World Class Supplier Program” in Chile, leading to
significant employment growth [23].
Examples of adverse health impacts from TNCs are:
• In 1998, at a time when the largest number of HIV/AIDS afflicted
people lived in South Africa, 41 transnational drug companies sued
the government of South Africa for initiating measures to reduce
prices of anti-retrovirals [24].
• Coca Cola’s depletion and pollution of groundwater in India to make a
product with 10 teaspoons of sugar per serving, contributing to global
epidemics of obesity and diabetes [25].
• In June 2009 an outbreak of E.coli food poisoning in the United
States was linked to Toll House refrigerated cookie dough
produced by Nestlé at a plant in Danville, Virginia. The company
recalled all Toll House products in the country, but it came to
light that the plant had previously refused to give inspectors from
the federal Food and Drug Administration (FDA) access to internal
records relating to matters such as pest control and consumer
complaints [26].
• The 1984 toxic gas leak from the Union Carbide chemical plant in
India, which included the loss of life of thousands of people in Bhopal
where the community still suffers the aftermath and is campaigning
for adequate clean-up, compensation and justice [27].
• Philip Morris Asia Limited sued the Australian government to repeal
plain packaging laws despite the fact that 1 billion tobacco-related
deaths are predicted globally this century [28].
• Tax avoidance strategies by McDonald’s global operations have
potentially cost European governments 1.0 billion Euros and
the Australian Government $497 million dollars in unrealised
receipts between 2009 and 2013 alone, reducing amounts
government have to invest in health promoting infrastructure
and services [29].
• Extractive industries have huge negative environmental and social
impacts. Since the Australian TNC BHP began mining in Papua New
Guinea in the 1980s, hundreds of millions of tons of waste have been
dumped into the Tedi River causing irreversible damage to the river
ecology and mass deforestation of surrounding areas and resultant
health impact on Indigenous peoples [30].
• A narrative review indicated that pharmaceutical corporations suppress
and misinterpret scientific evidence which leads to systematic
overestimation of the safety and efficacy of products, and also exerts
pressure on regulatory bodies against disclosure of adverse effects
which are deemed to be ‘trade secrets’ [31].
These examples are indicative, but not exhaustive, of the scope of
cumulative local, regional, national and global health impacts that
potentially result from the activities of TNCs. They are also indicative of
the ways in which the economic power of TNCs is likely to influence
the pressures on governments and other stakeholders to make trade-
offs between economic and social goals within processes of national
development.
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has developed an overarching analytical framework and
systematic methodology that can be used to assess the
impacts of TNC practices on populations within coun-
tries from a health equity perspective.Methods
Bellagio meeting: developing a corporate health impact
assessment
Our meeting was held in Bellagio in April 2015 and was
attended by representatives from academia, civil society
and TNCs. Its main aim was to discuss the usefulness
and feasibility of conducting a corporate health impact
assessment with a focus on its application in low and
middle income countries. The meeting oriented its dis-
cussion on the practices and health impacts of corpora-
tions in the food and beverage (excluding alcohol) and
extractive industry sectors. Discussions were held on the
viability of developing and implementing a corporate
health impact assessment from the perspectives of health
equity researchers; of activists campaigning against nega-
tive health aspects of corporate practices and corpora-
tions globally, nationally or within particular
communities; and corporations representative of our
two focal sectors (food/beverage and extractive indus-
tries). This follows development of a range of other tools
being used to assess TNC performance [6, 12, 13]. Our
CHIA framework augments these other approaches be-
cause it seeks to assess individual TNCs across the full
scope of their structures and practices; provides a tool to
compare a TNC’s practices across countries; and is fo-
cused specifically on health and health equity impacts.
Workshop participants agreed that corporations have
both positive and negative impacts on health, and that
government oversight is important in minimising the
negative impacts. Civil society activists and researchers
stressed significant detrimental environmental impacts,
dislocation of traditional communities, unsafe working
conditions leading to high rates of injury and death, and
the adverse impact of unhealthy products. The corporate
sector representatives emphasised the potential for gains
in areas such as employment standards, workplace safety
and environmental sustainability, and through corporate
policies to address social responsibility or create ‘shared
value’.
Although there was some concern about the processes
that would be involved in a corporate HIA all partici-
pants agreed that such a tool would be helpful especially
as it would focus on the operations of individual corpo-
rations including their entire supply chain. Table 2 de-
scribes the ways in which this was seen to be the case by
different groups of participants.
Participants also discussed the criteria by which corpo-
rations would be selected for corporate health impact as-
sessment (CHIA). This decision would be informed by a
consideration of the characteristics of the industry sec-
tors in which a TNC operates, and the characteristics of
the TNC itself (including brand profile, the countries in
which it operates and its scope of operations across a
supply chain). Further considerations are the type and
Table 2 Predicted value of Corporate Health Impact
Assessment
Predicted value to researchers
Evidence to inform public policy decisions
Evidence elucidating the health and health equity impacts of
individual TNCs’ structures, products and practices; and how these
differ between countries
Understanding of how TNC practices affecting health are influenced
by international and national regulatory structures
Predicted value to civil society activists
Advocacy tool to enhance community capacity to understand and
engage on issues associated with health impact of TNC operations
Facilitate community involvement in debates about TNC health
impact and possible government response
Predicted value to corporations
Evidence to inform corporate policies and practices to reduce adverse
and optimise positive impacts on health and health equity within
their countries of operation; and to achieve greater equity of practices
across countries
Predicted value to governments and policy-makers
Evidence to inform policy decisions regarding project approval and
appropriate regulation
Baum et al. Globalization and Health  (2016) 12:27 Page 4 of 7likely quality of information on the TNC’s operations,
the capacity of the research team within the countries in
which the TNC operates, and the level of civil society
interest. Given our interest in the impact of regulation it
would also be desirable to select TNCs which operate in
countries with widely varying regulatory environments.
Considerable discussion was held about how effective
engagement with affected communities within countries
could be integral to the conduct of a CHIA. Recognising
that HIA methodology has been criticised for being very
technical and, for example, not treating community
knowledge as legitimate, the meeting was adamant that
effective CHIA would rely on at least effective commu-
nity engagement processes and in some instances should
be community-driven when the capacity exists within
civil society.
Assessing health impact
Health impact assessment (HIA) has been used over
many years to produce evidence-based recommenda-
tions to inform decision-making about proposed pro-
jects, plans, programs and policies in order to maximise
their positive and minimise their negative impacts on
health. HIA stresses the importance of defining health
impacts broadly by including social, environmental and
economic factors that determine health and health
equity outcomes [14–17]. The workshop was interested
in the adaptation of HIA to consider health impacts ei-
ther concurrently or retrospectively (ex post) in terms of
existing or past TNC practices, or prospectively and pre-
dictively (ex ante) to ascertain likely impacts when newoperations are proposed. An ex ante HIA forecasts po-
tential impacts as part of the planning, design and ap-
proval of an intervention. Ex post assessment identifies
actual impacts during and after implementation [18, 19]
and provides an evidence base for corrective actions to
be taken if necessary, and to inform ex ante HIAs. HIA
incorporates five steps: screening, scoping, identification,
assessment, decision-making and recommendations, as
well as evaluation and follow-up. In examining the
feasibility of applying HIA to corporate practices the
workshop acted as the scoping stage of a HIA process. It
also then developed a framework within which the iden-
tification and assessment stages could be conducted.
Results and discussion
Framework for corporate health impact assessment
A draft framework to guide the design and implementa-
tion of CHIA was presented to the participants on the
first day of the meeting. This was then extensively re-
vised over the following two days, through detailed dis-
cussion about the importance of understanding the
direct and indirect mechanisms by which TNCs affect
health. The discussion also highlighted the importance
of studying a TNC’s global, national and local operations
and so emphasising the need for the framework to be
adaptable to different contexts. This discussion resulted
in the framework shown in Fig. 2.
An overview of the content of the framework is
provided below:
A. Context: global operating context (history of TNC;
effect on TNC of global regulatory environment
including trade agreements; mapping of links
between political and TNC elites); supply chain
analysis spanning primary production, processing,
manufacturing, transport, retail and consumption;
national operating environment (agreements
between TNC and government, description of
national regulatory environments, national
corruption index, activities of industry associations);
regional community or groups affected by the TNC’s
activities within the LMIC (description of regions
and communities and groups affected).
B. Structure, products and practices of TNCs:
organisational structure, political financing and
lobbying practices, and business practices including
board membership and business affiliations,
corporate philanthropy and sponsorships, use of
health impact assessment (HIA), environmental
impact assessment (EIA) and TNC products
including energy and nutrient components, and
distribution and forms of creative and integrated
marketing especially targeted to children and
young people.
Fig. 2 Framework for conducting a corporate health impact assessment
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categories allow for the possibility of recognising
both positive and adverse impacts on health in any
of these domains:Workforce and working conditions (eg.
description, occupational health systems,
remuneration of workers in relation to cost of
living indexes, extent of unionisation, quality of
provision of health care and impact on social
determinants of health such as housing).
Social conditions (eg. impact of TNC goods on
locally produced goods and services and net
employment levels, impact of operation on local
living conditions, the value of corporate social
responsibility initiatives, social dynamics createdby TNC operations including impact of fly-in-fly-
out workers, impacts on social, cultural and
spiritual life, and the impact of migrant labour
in mines affecting sexual practices).
Environment (eg. impact on natural systems in
ways that affect health or health risk, including
air/water quality, exposure to pollutants, land
clearing, energy consumption, water, waste
disposal).
Consumption patterns (eg. impact of quality and
consumption of TNC goods on health, national
marketing practices).
Economic mediated impact on health (eg.
impact on TNC operations on overall economic
conditions including tax revenues, reliance and
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economic and health impacts on local businesses/
farmers).Standard HIA data-gathering methods include litera-
ture sources, and collection of quantitative and qualita-
tive information, including both primary and secondary
data. Primary data are used explicitly for the HIA, such
as community consultations or stakeholder interviews.
Secondary data include relevant peer reviewed articles
and routine data collected by companies or governments
that is used for other purposes. Following standard data
gathering methods, evidence relating to each domain in
the framework would be collected through a mix of:
analysis of key documents (such as corporate policies,
reports and media releases, government or international
agency reports); interviews with key players (including
corporate actors, lobbyists, current and former political
staff, members of non-government organisations and af-
fected communities within the countries concerned);
and searches of databases for evidence on impacts of the
TNCs on health. The information collected in each of
the above domains would be analysed to determine the
likely impacts of the TNC’s operations on overall popu-
lation health and health equity. This analysis would also
determine which groups within the affected country
would be particularly subject to adverse health impacts
and which would gain health benefits from the TNC’s
operation.
The framework is designed to be applied to corpora-
tions within countries. We anticipate that the CHIA will
have to cover very different contexts and will have to be
adapted to local conditions. We acknowledge that in
some countries it will be easier to collect a robust set of
data than in others. Applying the CHIA framework to
the operations of one TNC within several countries
would then enable a comparison of health impacts in
different national settings, and some assessment of the
overall impact of the TNC. A major advantage of the
cross-national comparison was seen to be the ability to
determine from this information the impact of different
national regulatory structures on the ways in which cor-
porations operate. It would also permit comparisons
among different corporations.
The meeting considered the CHIA framework to be
most likely used by civil society activists, with academic
research support, for advocacy purposes. However it was
noted at the meeting that TNCs are increasingly con-
cerned about their public image in response to concerns
expressed by activist civil society groups, shareholder ac-
tivism and potential employees who desire to work for
an ethical company. Consequently, in some circum-
stances TNCs may choose to co-operate with the CHIA
process (e.g. sharing more of their internal documentsand participating in the assessment itself ) and to use the
results to inform their own operations. In the event
TNCs decide not to co-operate the CHIA process would
still be possible from publicly available documents,
media and data collection from those experiencing the
health impacts. As local and national governments de-
velop capacity in HIA [20], some may choose to apply
this approach to corporate practices as well as to public
projects. The necessary skills and capacities for under-
taking a CHIA include a multi-disciplinary team, legal
expertise on the structure and operations of TNCs, un-
derstanding the role and practice of health impact as-
sessments, and public health expertise to determine the
health impacts. Other necessary expertise includes that
relating to the products or practices of particular types
of TNCs; for example nutrition experts for food industry
TNCs and occupational health and safety expertise for
extractive industry TNCs. A civil society perspective is
also necessary for informing a CHIA.
Conclusions
In our continually globalising world, TNCs have a power-
ful impact on health and well-being in almost every coun-
try on earth. This impact is mediated through the
business and political practices of the TNCs, the types of
regulatory environments in which they operate and over
which they have increasing influence, TNCs’ employment
and environmental practices, and the ways in which their
operations affect communities, regions and countries.
There has been very little systematic investigation of the
health equity impacts of these corporations. Our Bellagio
meeting enabled a detailed consideration of the value,
challenges and practicalities of conducting such systematic
studies using the methodology we propose. It suggested
that there will be significant benefits in documenting these
health effects through a formal corporate health impact
assessment process. The meeting was clear that the CHIA
should be linked to the overarching aim of reducing eco-
nomic inequality and social injustice. The results would
be available for use by civil society advocates, corporations
who wish to lessen the adverse health impact of their op-
erations and by governments who would be able to assess
different regulatory frameworks according to their ability
to reduce adverse health and equity impacts and/or en-
hance health benefits of TNC operations.
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